Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7590192

Concept 2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
2020-06-01 to
2021-05-31
2020-06-01 to
2021-05-31
2020-06-01 to
2021-05-31
2020-06-01 to
2021-05-31
2020-06-01 to
2021-05-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
6,553,000,000 JPY
5,979,000,000 JPY
5,908,000,000 JPY
5,111,000,000 JPY
Non-operating income
Non-operating income
205,000,000 JPY
288,000,000 JPY
197,000,000 JPY
270,000,000 JPY
Non-operating expenses
Non-operating expenses
29,000,000 JPY
27,000,000 JPY
39,000,000 JPY
38,000,000 JPY
Ordinary profit (loss)
6,729,000,000 JPY
6,240,000,000 JPY
6,067,000,000 JPY
5,342,000,000 JPY
Extraordinary income
Extraordinary income
269,000,000 JPY
276,000,000 JPY
125,000,000 JPY
125,000,000 JPY
Extraordinary losses
Extraordinary losses
278,000,000 JPY
255,000,000 JPY
318,000,000 JPY
360,000,000 JPY
Profit (loss) before income taxes
6,720,000,000 JPY
6,262,000,000 JPY
5,873,000,000 JPY
5,107,000,000 JPY
Income taxes - current
2,213,000,000 JPY
1,989,000,000 JPY
1,805,000,000 JPY
1,496,000,000 JPY
Income taxes - deferred
-120,000,000 JPY
-138,000,000 JPY
-89,000,000 JPY
-75,000,000 JPY
Profit (loss)
4,412,000,000 JPY
4,627,000,000 JPY
4,412,000,000 JPY
4,412,000,000 JPY
4,412,000,000 JPY
3,686,000,000 JPY
4,157,000,000 JPY
3,686,000,000 JPY
3,686,000,000 JPY
3,686,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.